<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02847533</url>
  </required_header>
  <id_info>
    <org_study_id>API/2014/50</org_study_id>
    <nct_id>NCT02847533</nct_id>
  </id_info>
  <brief_title>Inflammatory Markers and Resistant Depression</brief_title>
  <acronym>InDep</acronym>
  <official_title>Inflammatory Markers and Resistant Depression</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Besancon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Besancon</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study focuses on blood inflammatory markers (pro-inflammatory cytokines,
      anti-inflammatory cytokines, monocytes costimulation molecules) in patients with resistant
      unipolar depression in comparison with non-resistant unipolar depressed patients.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>September 2016</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">June 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>plasmatic concentration of Interleukin 6</measure>
    <time_frame>at patient inclusion</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>concentration of proinflammatory cytokine</measure>
    <time_frame>at patient inclusion</time_frame>
    <description>Expression intensity of monocytes costimulation molecules</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>concentration of antiinflammatory cytokine</measure>
    <time_frame>at patient inclusion</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>functional polymorphisms of expression genes of inflammatory proteins</measure>
    <time_frame>at patient inclusion</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>plasmatic concentration of Retinoid X receptor signaling pathway</measure>
    <time_frame>at patient inclusion</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Expression rate of monocytes costimulation molecules</measure>
    <time_frame>at patient inclusion</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">108</enrollment>
  <condition>Depression</condition>
  <arm_group>
    <arm_group_label>resistant depression</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>patients suffering from resistant unipolar depression (at least 2 failed antidepressant treatments for the current episode)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>non resistant depression</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>patients in remission from unipolar depressive disorder</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>blood sample</intervention_name>
    <description>blood sample for concentration levels of inflammatory markers</description>
    <arm_group_label>resistant depression</arm_group_label>
    <arm_group_label>non resistant depression</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>psychometric scales</intervention_name>
    <description>Mini international interview MADRS, C-SSRS, QIDS-SR, BIS-10, BDHI, BART, ERD</description>
    <arm_group_label>resistant depression</arm_group_label>
    <arm_group_label>non resistant depression</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  group 1: Patients with resistant MDD (at least 2 failed treatments for the current
             episode) ,current treatment with IRS or IRSNA,

          -  group 2: patients with MDD remission after response to an antidepressant treatment.

        Exclusion Criteria:

          -  comorbid somatic or psychiatric disorders: chronic or acute inflammatory diseases,
             previous treatment with brain stimulation for the current episode, legal protection
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Emmanuel Haffen, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU Besançon</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Emmanuel Haffen, MD PhD</last_name>
    <phone>0033381218388</phone>
    <email>ehaffen@chu-besancon.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Julie Monnin, PhD</last_name>
    <phone>0033381218543</phone>
    <email>jmonnin@chu-besancon.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHU Besançon</name>
      <address>
        <city>Besançon</city>
        <zip>25000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Sophie Depierre</last_name>
      <phone>03841218745</phone>
      <email>sdepierre@chu-besancon.fr</email>
    </contact>
    <investigator>
      <last_name>Emmanuel Haffen, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pierre Vandel, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Djamila Bennabi, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nazim Nekrouf, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Julie Giustiniani, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Caroline Masse-Sibille, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 21, 2016</study_first_submitted>
  <study_first_submitted_qc>July 25, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 28, 2016</study_first_posted>
  <last_update_submitted>July 25, 2016</last_update_submitted>
  <last_update_submitted_qc>July 25, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 28, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>resistant depression</keyword>
  <keyword>inflammation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depression</mesh_term>
    <mesh_term>Depressive Disorder</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

